Eli Lilly and Company announced Wednesday that it has partnered with Walmart to make its popular weight-loss drug Zepbound more accessible to patients across the United States — even for those without insurance coverage.
Starting next month, customers with a valid prescription will be able to purchase single-dose vials of Zepbound directly from Walmart pharmacies nationwide or have them delivered to their homes.
